ArticleOncotarget2017

VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of Bim.

Nurulhuda Mustafa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.